Colchicine

秋水仙碱

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameColchicine
Drug Alias NameColchicine USP秋水仙素秋水仙硷秋水侧碱Mitigare +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Aortic valve diseasesIschemic Stroke +[69] 
Global Approved IndicationsFamilial Mediterranean FeverArthritis, GoutyGout
Approved Indications in ChinaArthritis, Gouty
Original Approved Country/TerritoryMainland China
Original Approved Date1995/01/01
Country/TerritoryCzechiaBelgiumArmenia +[43] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesURL Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of BrawijayaSt. Vincent Cardiovascular Research InstituteAzienda Sanitaria Locale Asl 6, Livorno +[42] 
Inactive CompaniesMiami Cardiac And Vascular InstituteInstituto Nacional De Ciencias Medicas Y Nutricion Salvador ZubiranShifa Tameer-E-Millat University +[22] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Aortic valve diseasesIschemic Stroke +[50] 
Inactive IndicationsPostoperative ComplicationsHypertriglyceridemiaMetabolic Diseases +[19] 

Other Information

ATC CodeM04AC01
Related LinksWikipediaDrugBankKEGG